177Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-risk Neuroblastoma

NCT04903899 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Neuroblastoma Recurrent
Neuroblastoma

Interventions

COMBINATION_PRODUCT: 177Lu-DOTATATE

Sponsor

Jakob Stenman

Collaborators

[object Object]
[object Object]